Project Grant HT94252510609
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$320K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This federal Project Grant award of $932,498.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. Specifically, the award to the Regents of the University of Michigan will fund a research project titled "Non-Invasive CNS Delivery of Immunocytokines for Sustained Expansion of Tregs and Treatment of ALS". The research...
The Defense Health Agency awarded a $997,343 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a multidimensional imaging data-driven approach for phenotyping multiple sclerosis. The research aims to transform healthcare for military service members and the broader public through innovative and impactful biomedical investigations spanning basic, applied, and translational research. The award period runs from...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
The U.S. Department of Defense's Defense Health Agency has awarded a $780,000 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "LEAD EXPOSURE AND SEX-SPECIFIC PROGRAMMING OF CARDIOVASCULAR DISEASE ACROSS THE LIFE COURSE", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
The University of Michigan will receive $780,000 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to conduct a mixed-methods study from September 2021 through August 2024. The study will examine the risk of Alzheimer's disease and related dementias among people with spinal cord injuries, comparing veterans and civilians. Through supporting innovative medical research, the Military Medical Research and Development program...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
The Defense Health Agency awarded a $997,146.00 Project Grant to Cedars-Sinai Medical Center to investigate lesion-specific mechanisms driving retrograde transsynaptic degeneration of the visual axis in multiple sclerosis. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for Service Members and the public. The project will be conducted from September 30, 2023 to September 29, 2026 at...